MPLT

NASD MapLight Therapeutics, Inc.
Oct 2, 2026 · 4:04 PM ET LAST TRADE Market Closed

$9.87 ↑ +0.24 (+2.47%) Trading Up from the previous close of $9.63, $0.30 below the day’s high of $10.17

YTD change
-43.82%
vs 20-day SMA
-15.80%
vs 200-day SMA
-54.24%

Price ranges

Previous day
$9.57 $10.17
open $10.16 close $9.63
-$0.53 (-5.22%)
Today
$9.43 $10.17
open $9.70 now $9.87
+$0.17 (+1.73%)
Past week
$9.57 $10.87
from $10.76 now $9.87
-$0.89 (-8.29%)
Past month
$9.57 $14.22
from $13.06 now $9.87
-$3.19 (-24.44%)
This year
$9.10 $40.43
from $17.57 now $9.87
-$7.70 (-43.82%)

Price & Performance

-11.54 (-54.51%) / 6M

$7.22$18.88$30.55$42.21Apr 2Jul 2Oct 1

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor
  • The stock is 75.6% away from all-time highs of $40.43
  • MPLT is down 44% since the beginning of the year
  • MPLT is down 46% over the past 12 months
  • MPLT is down 24% over the past 1 month
  • 29% of all MPLT investors are betting against MPLT

MPLT reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -47.5%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-1.32
Earnings momentum -11.6% Quarterly EPS growth
Quarterly change -11.6%

Valuation

P/E ratio N/A
Enterprise value $134.8M
Beta 2.57

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$304.7M
Debt$2.0K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap $548.4M

MapLight Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapeutics for brain disorders. It develops the ML-007-MA product for treatment of schizophrenia and ADP. Its platforms include Optogenetics, Transcriptnomics, and STARmap. The company was founded by Christopher A. Kroeger, Karl Deisseroth, Robert Malenka, and Karoly Nikolich in November 2018 and is headquartered in Redwood City, CA.

Competitor comparison

TickerCompany PriceChange
LLY Eli Lilly and Company $1,149.85 -0.62%
JNJ Johnson & Johnson $258.66 -2.30%
ABBV AbbVie, Inc. $259.93 -0.63%
MRK Merck & Co., Inc. $143.81 -1.03%
RHHVF Roche Holding Ltd $442.60 +6.66%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.